The impact of residual extra-retroperitoneal masses in patients with advanced non-seminomatous germ cell testicular cancer

被引：1
|
作者：
Shayegan, B
Carver, BS
Bosl, GJ
Bajorin, DF
Motzer, RJ
Sheinfeld, J
机构：
来源：
JOURNAL OF UROLOGY | 2006年 / 175卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)32705-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
449
引用
收藏
页码：145 / 146
页数：2
相关论文
共 50 条
  • [41] Bone marrow metastasis in a patient with non-seminomatous testicular germ cell tumor
    Ueda, Takashi
    Takada, Ippei
    Shimizu, Teruki
    Ito, Saya
    Fujihara, Atsuko
    Shiraishi, Takumi
    Nakamura, Terukazu
    Ukimura, Osamu
    IJU CASE REPORTS, 2022, 5 (04) : 247 - 250
  • [42] Is Modified Retroperitoneal Lymph Node Dissection Alive for Clinical Stage I Non-Seminomatous Germ Cell Testicular Tumor?
    Basiri, Abbas
    Ghaed, Mohammad Ali
    Simforoosh, Nasser
    Tabibi, Ali
    Danesh, Abdolkarim
    Nouralizadeh, Akbar
    Parizi, Mehdi Kardoust
    UROLOGY JOURNAL, 2013, 10 (02) : 873 - 877
  • [43] SEOM guidelines: non-seminomatous germ cell cancer (NSGCC)
    Pablo Maroto
    Xavier García del Muro
    Javier Sastre
    Dolores Isla
    Clinical and Translational Oncology, 2011, 13 : 565 - 568
  • [44] Distinct Proteomic Profile of Spermatozoa from Men with Seminomatous and Non-Seminomatous Testicular Germ Cell Tumors
    Selvam, Manesh Kumar Panner
    Alves, Marco G.
    Dias, Tania R.
    Pushparaj, Peter N.
    Agarwal, Ashok
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (14) : 1 - 10
  • [45] Retroperitoneal relapse of non-seminomatous testicular cancer: computed tomography findings before retroperitoneal lymphadenectomy.
    Hosten, N
    Stroszczynski, C
    Rick, O
    Lemke, M
    Felix, R
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 1999, 170 (01): : 61 - 65
  • [46] Retroperitoneal lymph node dissection as adjuvant therapy in the treatment of non-seminomatous testicular cancer
    Thijssens, K
    Vaneerdeweg, W
    Schrijvers, D
    Eyskens, E
    Van Oosterom, A
    ACTA CHIRURGICA BELGICA, 2003, 103 (06) : 599 - 602
  • [47] Risk factors for relapse in non-seminomatous testicular cancer after postchemotherapy retroperitoneal lymph node dissection with viable residual cancer
    Antonelli, L.
    Ardizzone, D.
    Tachibana, I
    Adra, N.
    Cary, C.
    Sexton, W. J.
    Bagrodia, A.
    Mego, M.
    Daneshmand, S.
    Nicolai, N.
    Nazzani, S.
    Heidenreich, A.
    Paffenholz, P.
    Saoud, R.
    Eggener, S.
    Oswald, N.
    Tryakin, A.
    Naoun, N.
    Cazzaniga, W.
    Nicol, D.
    Gerdtsson, A.
    Tandstad, T.
    Fizazi, K.
    Fankhauser, C. D.
    EUROPEAN UROLOGY, 2024, 85 : S724 - S725
  • [48] Positron emission tomography (PET) is not indicated in the postchemotherapy evaluation of advanced non-seminomatous testicular germ cell tumors
    Aparicio, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (05): : 509 - 510
  • [49] SUCCESSFUL RESECTION OF POST-CHEMOTHERAPY METASTASES FROM NON-SEMINOMATOUS GERM CELL TESTICULAR CANCER
    Morelli, Franco
    Capotorto, Anna Maria
    Lombardi, Lucia
    Setola, Pasquale
    Sebastio, Nicola
    Cisternino, Antonio
    Maiello, Evaristo
    ANTICANCER RESEARCH, 2010, 30 (04) : 1424 - 1425
  • [50] Positron emission tomography (PET) is not indicated in the postchemotherapy evaluation of advanced non-seminomatous testicular germ cell tumors
    J. Aparicio
    Clinical and Translational Oncology, 2014, 16 : 509 - 510
12345